Journal profile
MCBS Molecular and Cellular Biomedical Sciences
ISSN 2527-4384 · eISSN 2527-3442 · Cell and BioPharmaceutical Institute · Indonesia
MCBS Molecular and Cellular Biomedical Sciences: fully open access; APC about USD 35; review about 20 weeks (community reports); 21 articles in 2025.
Scope
Aims, scope and focus
MCBS Molecular and Cellular Biomedical Sciences is published by Cell and BioPharmaceutical Institute. By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Medicinal Plant Research and Adipokines, Inflammation, and Metabolic Diseases, together about 29.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Molecular and Cellular Biomedical Sciences (MCBS) is an Indonesian, open access, peer-reviewed journal that supports all topics in Biology, Pathology, Pharmacology, Biochemistry, Histology and Biomedicine in the aspect of molecular and cellular. MCBS is dedicated to publishing review and research articles. The editors will carefully select manuscript to be delivered for the peer-reviewing process. MCBS is an open journal for all countries and seeks to advance Indonesian research and publications.
From the journal's Aims & Scope
Editor-in-chief Gerard PalsPublisher website
Editorial board by country: none in mainland China; most named Indonesia 5, United States 2, Japan 2, Taiwan, China 1, South Korea 1 (14 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine13.1%
- Medicinal Plant ResearchAgricultural and Biological Sciences10.9%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.1%
- Skin Protection and AgingMedicine4.6%
- COVID-19 Clinical Research StudiesMedicine4%
- SARS-CoV-2 and COVID-19 ResearchMedicine4%
- Computational Drug Discovery MethodsComputer Science4%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
The Prodia Education and Research InstitutePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 12OpenAlex ·
- i10-index
- 15OpenAlex ·
- 2-year mean citedness
- 0.95OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 180 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 14 | 14 | 82 |
| 2025 | 21 | 21 | 107 |
| 2024 | 21 | 21 | 136 |
| 2023 | 21 | 21 | 193 |
| 2022 | 21 | 21 | 123 |
| 2021 | 21 | 21 | 59 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 20 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 35 | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≤ 8
- Manuscript length
- ≤ 3,500 words
- Reference style
- Vancouver
- Templates
- Word
Article types accepted2, with length limits
- research articleReview Article: Review Article should consist of no more than 5,000 words, not including the words in abstract, references, table, figure, and figure legend. Th…main text ≤ 3,500 words
- review articleReview Article: Review Article should consist of no more than 5,000 words, not including the words in abstract, references, table, figure, and figure legend. Th…main text ≤ 5,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- Authorship Authorship Criteria
Authorship provides credit for an author's contributions to a study and carries accountability. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, analysis and interpretation, as well as manuscript preparation and revision. Transparency about the contributions of authors is encouraged. In order to qualify for authorship of the submi…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Policy
A conflict of interest exists when professional judgment concerning a primary interest may be influenced by a secondary interest. These instructions are based on ICJME recommendation for scholarly work in medical journal: Author’s Conflict of Interest At the point of submission, Molecular and Cellular Biomedical Sciences (MCBS) requires that each author reveals any personal and/or financial intere…
Source ↗Publisher website ·- Data availability Data Sharing and Reproducibility
To enable the openness, transparency, reproducibility and verification of data, Molecular and Cellular Biomedical Sciences (MCBS) encourages authors to share information related with their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods and materials. MCBS also requires data sharing plans for registered clinical trials. Any clinical t…
Source ↗Publisher website ·- Publication ethics Allegations of Misconduct
Scientific misconduct is a wilful violation of standard codes of scholarly conduct and ethical behaviour in the publication of professional scientific research, which includes fabrication, falsification, or plagiarism in proposing, performing, reviewing research, or in reporting research results. Misconduct represents a tremendous attack on the values upon which science is based, and will be taken…
Source ↗Publisher website ·- License & copyright Copyright Notice
Author/s who publish in MCBS will transfer the copyright of their work to PERI. By submitting a manuscript, the author/s agree that the copyright of their manuscript is transferred to PERI, if and when the manuscript is accepted for publication. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. However, the copyright will be released …
Source ↗Publisher website ·- Open access Open Access Policy
Copyright: upon acceptance, authors are allowed to hold the copyright without any restriction. Model summary
MCBS provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer Review Process
All manuscripts are subjected to peer review. Model summary
All manuscripts submitted to Molecular and Cellular Biomedical Sciences will be selected and double-blind peer-reviewed by two or more reviewers to present valuable and authentic findings. Author can suggest reviewer/s that not having publication together within five years and should not be member/s of the same research institution. However, reviewers will be selected independently by Section Edit…
Source ↗Publisher website ·- Plagiarism Plagiarism Screening Policy
Originality: manuscripts must not be previously published or under consideration elsewhere. Model summary
Plagiarism is strictly forbidden, and by submitting the manuscript for publication the author/s agree that the publishers have the legal right to take appropriate action against the author/s if plagiarism or fabricated information is discovered. All manuscripts submitted to Molecular and Cellular Biomedical Sciences will be screened for plagiarism by using Turnitin and/or Crossref Similarity Check…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Cell and BioPharmaceutical Institute
- Country or region
- Indonesia
- Language
- English
- ISSN
- 2527-4384
- Electronic ISSN
- 2527-3442
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about MCBS Molecular and Cellular Biomedical Sciences
How long does peer review take at MCBS Molecular and Cellular Biomedical Sciences?
Authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of MCBS Molecular and Cellular Biomedical Sciences?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 8; Manuscript length: ≤ 3,500 words; Reference style: Vancouver; Templates: Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of MCBS Molecular and Cellular Biomedical Sciences based?
Of the 14 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Indonesia (5), United States (2) and Japan (2). Counted from the institutions listed on the board page; for reference only.
Which databases index MCBS Molecular and Cellular Biomedical Sciences?
According to LetPub and DOAJ records, MCBS Molecular and Cellular Biomedical Sciences is indexed in DOAJ.
Is MCBS Molecular and Cellular Biomedical Sciences open access, and what is the APC?
MCBS Molecular and Cellular Biomedical Sciences is a fully open-access journal. APC about USD 35.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .